TVM UK has launched Vetbromide, the only potassium bromide formulation licensed for both adjunct AND monotherapy indications in dogs with idiopathic epilepsy.

Vetbromide is presented as a 600mg double divisible tablet for both large and small dogs, and for greater flexibility with dose titration. Tablets are blister packed for ease of storage and dispensing, with a four-year unopened shelf life.

Alongside the launch, TVM has prepared a range of product support materials, including: product guidelines, treatment and monitoring guidelines, seizure management ‘lunch and learn’ sessions, and pet owner information.

TVM has also created a free e-learning tool which takes veterinary staff through the process of diagnosing, treating and monitoring dogs with suspected epilepsy.

Will Peel, product manager at TVM said: "The addition of Vetbromide to our epilepsy range allows vets more flexibility when treating epileptic patients. To further assist vets, we are also offering a wide range of free literature and in-practice support to ensure that veterinary staff are up to speed on such a common, yet at times complicated, topic.’

For more information, visit www.tvm-uk.com/epilepsy, or contact your TVM UK Territory Manager.


Whilst you're here, take a moment to see our latest job opportunities for vets.